1. 3doctors
2. eviltaskmaster
3. beachgirlxoxo
4. oneltonfan
1.beachgirlxoxo 01/29/2018
Goldman Sachs initiates as a sell, $32PT
2.oneltonfan 05/08/2018
Sees FY18 EPS of $1.19-1.21
3.beachgirlxoxo 02/08/2018
Myriad's myRisk® Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation
4.oneltonfan 05/08/2018
Yes ahah
5.beachgirlxoxo 06/21/2018
Top-Five National Payer Issues Positive Coverage Decision for Myriad's Prolaris® Test for Prostate Cancer
6.eviltaskmaster 05/08/2018
I am seeing $40s
7.beachgirlxoxo 02/06/2018
Beats EPS estimates by $0.07 and beats on revenues
8.beachgirlxoxo 01/15/2018
Awesome news
9.oneltonfan 02/21/2018
NCCN Guidelines Broadly Endorse Biomarker Testing in Prostate Cancer
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW